Approach to and management of the acute stroke patient with atrial fibrillation: A literature review

Marmagkiolis, Konstantinos; Nikolaidis, Ioannis G.; Politis, Themos; Goldstein, Lawrence J.

doi:10.1002/jhm.343

Cited by 3 publications

(4 citation statements)

References 66 publications

(74 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Atrial fibrillation (AF) is the most common cardiac arrhythmia and is strongly associated with increased risk of morbidity, such as stroke and thromboembolism. 1 Atrial fibrillation is considered an epidemic, affecting 1 -1.5% of the population in the developed world. 2 The risk increases with age, 3 and the prevalence is projected to grow at least three-fold by 2050.…”

Section: Introductionmentioning

confidence: 99%

The cost of illness of atrial fibrillation: a systematic review of the recent literature

Wolowacz¹,

Samuel²,

Brennan³

et al. 2011

Europace

209

124

View full text Add to dashboard Cite

Atrial fibrillation (AF) is the most common cardiac arrhythmia, its prevalence increasing markedly with age. Atrial fibrillation is strongly associated with increased risk of morbidity, including stroke and thromboembolism. There is growing awareness of the economic burden of AF due to ageing populations and constrained public finances. A systematic review was performed (1990-2009). Cost studies for AF or atrial flutter were included; acute-onset and post-operative AF were excluded. Total, direct, and indirect costs were extracted. Of 875 records retrieved, 37 studies were included. The cost of managing individual AF patients is high. Direct-cost estimates ranged from $2000 to 14,200 per patient-year in the USA and from €450 to 3000 in Europe. This is comparable with other chronic conditions such as diabetes. The direct cost of AF represented 0.9-2.4% of the UK health-care budget in 2000 and had almost doubled over the previous 5 years. Inpatient care accounted for 50-70% of annual direct costs. In the USA, AF hospitalizations alone cost ∼$6.65 billion in 2005. In this first systematic review of the economic burden of AF, hospitalizations consistently represented the major cost driver. Costs and hospitalizations attributable to AF have increased markedly over recent decades and are expected to increase in future due to ageing populations.

show abstract

Section: Introductionmentioning

confidence: 99%

The cost of illness of atrial fibrillation: a systematic review of the recent literature

Wolowacz¹,

Samuel²,

Brennan³

et al. 2011

Europace

209

124

View full text Add to dashboard Cite

show abstract

“…In all cases, without other contraindications, once AF is diagnosed OA should be considered for primary and secondary stroke prevention. Many large prospective randomised trials have shown that OA therapy lowers the risk of thromboembolic stroke by 70% in patients with AF [34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52]. Even if these trails did not involve paced subjects, there is no reason for excluding "a priori" them from prophylaxis with cumarins.…”

Section: Discussionmentioning

confidence: 99%

Type the Characteristics of Pacemaker (PM) Patients Admitted in Stroke Unit: The Stroke Pacemaker Study (SPACES)

Spinelli

2014

IBRR

View full text Add to dashboard Cite

Aims: According to recent surveys, despite health care authority's budget reductions, the total amount of PM implants increased worldwide. Even if the diffusion of these devices is large no data are available concerning the characteristics of PM patients hospitalized for stroke. Study Design:The SPACES study is a retrospective observational study conducted in 3 hospital centres including paced patients consecutively admitted for acute stroke. The objective is to determine the characteristics of patients with PM admitted in the stroke units.

show abstract

“…AF is a frequent complication of MS. A left atrial mural thrombus is a common finding, particularly in the left atrial appendage, in patients with mitral valve disease and AF. Specifically, patients with MS who develop AF increase their risk of cardioembolism by three to seven times . Therefore, all patients having MS with AF need long‐term anticoagulation therapy.…”

Section: Discussionmentioning

confidence: 99%

“…Specifically, patients with MS who develop AF increase their risk of cardioembolism by three to seven times. 8 Therefore, all patients having MS with AF need long-term anticoagulation therapy.…”

Section: Discussionmentioning

confidence: 99%

Is the thrombus truly free‐floating? A case report

Demir

Avcı

Altunkeser

et al. 2013

J of Clinical Ultrasound

View full text Add to dashboard Cite

A free-floating thrombus in the left atrium is very rare in mitral stenosis. Such a thrombus can lead to sudden circulatory arrest and syncope or can cause severe cerebral or peripheral thromboembolic events. Clinical diagnosis is difficult, but left atrial thrombus should be suspected if patients with mitral stenosis and atrial fibrillation have intermittent or changing murmurs, emboli, or syncope. We describe the case of a patient with mild mitral stenosis under warfarin therapy, and a left atrial pedunculated thrombus discovered during the investigation for syncope attacks.

show abstract

Approach to and management of the acute stroke patient with atrial fibrillation: A literature review

Cited by 3 publications

References 66 publications

The cost of illness of atrial fibrillation: a systematic review of the recent literature

The cost of illness of atrial fibrillation: a systematic review of the recent literature

Type the Characteristics of Pacemaker (PM) Patients Admitted in Stroke Unit: The Stroke Pacemaker Study (SPACES)

Is the thrombus truly free‐floating? A case report

Contact Info

Product

Resources

About